Showing 21 - 40 results of 47,502 for search '(( 01 0 decrease ) OR ((( 50 n decrease ) OR ( 50 ((nn decrease) OR (a decrease)) ))))', query time: 0.70s Refine Results
  1. 21
  2. 22
  3. 23

    Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50. by Khamis Mustafa (17941332)

    Published 2024
    “…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
  4. 24
  5. 25

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

    Published 2025
    “…<p>(A) Ki-67 expression in parathyroid glands of rats with CKD-induced sHPT treated with Cinacalcet either early in the inactive light phase (<i>Cina1</i>; N = 10) or early in the active dark phase (<i>Cina2</i>; N = 9) compared to untreated rats with sHPT investigated at similar time points (<i>PNX1</i>; N = 7 and <i>PNX2</i>; N = 7, respective) and to normal rats investigated at similar time points (<i>ctrl1</i>; N = 9 and <i>ctrl2</i>; N = 7, respective). …”
  6. 26
  7. 27

    Juvenile demyelination leads to a decrease in axonal complexity of PFC PV interneurons. by Sara Hijazi (21656615)

    Published 2025
    “…</i> Total proximal axonal length is decreased in cuprizone-treated PFC PV interneurons compared with control cells (<i>t test; n = 10/9 cells per group, **p < 0.01</i>)<i>. …”
  8. 28
  9. 29
  10. 30
  11. 31
  12. 32
  13. 33

    The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

    Published 2020
    “…<i>n</i> = 11 oocytes for WT (IC<sub>50</sub> = 0.68 ± 0.07 μM) and 11 oocytes for C456Y (IC<sub>50</sub> = 0.97 ± 0.1 μM), ***<i>P</i> < 0.001, Mann-Whitney. …”
  14. 34
  15. 35
  16. 36
  17. 37
  18. 38
  19. 39

    Elevated IDO activity in HD mouse brains is decreased by <i>ex-vivo</i> iron chelation. by David W. Donley (3111198)

    Published 2021
    “…<p>Mouse pups were supplemented with carbonyl iron from postnatal days 10–17 and then were sacrificed at 14 weeks of age. <b>A.</b> Striatal IDO activity is increased in N171-82Q HD mice and significantly decreased by <i>ex vivo</i> iron (III) chelation (50 μM deferoxamine). …”
  20. 40